8-K
filed February 22, 2023, 6:59 PM ET
ticker CCRN
CIK 0001141103
earnings
confidence high
sentiment negative
materiality 0.75
Cross Country Healthcare Q4 revenue down 2% YoY; guides Q1 revenue down ~25% YoY
CROSS COUNTRY HEALTHCARE INC
2022-FY EPS reported
$5.02
revenue$2,806,609,000
- Q4 revenue $628.2M (-2% YoY); net income $38.8M (-50% YoY); diluted EPS $1.05 vs $2.07.
- Full year 2022 revenue $2.8B (+67% YoY); net income $188.5M (+43% YoY); adjusted EBITDA $301.7M (+86%).
- Q1 2023 guidance: revenue $590-600M (down ~25% YoY); adjusted EBITDA $44-49M (down ~50% YoY).
- Completed acquisitions of Mint, Lotus, and HireUp in Q4; repurchased 0.4M shares for $10.9M.
- Made $100M optional prepayments on term loan in 2022; remaining $76.2M share repurchase authorization.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CROSS COUNTRY HEALTHCARE INC reported the full year ended December 31, 2022 results: revenue $2.8 billion, net income $188.5 million, EPS 5.02.
- Period
- the full year ended December 31, 2022
- Revenue
- $2.8 billion
- Net income
- $188.5 million
- EPS
- 5.02
- Result
- reported results
Exact text from the filing
For the year ended December 31, 2022, consolidated revenue was $2.8 billion, an increase of 67% year-over-year. Consolidated gross profit margin was 22.4%, consistent with the prior year. Net income attributable to common stockholders was $188.5 million, or 5.02 per diluted share, compared to $132.0 million, or $3.53 per diluted share, in the prior year.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
CROSS COUNTRY HEALTHCARE INC reported the fourth quarter ended December 31, 2022 results: revenue $628.2 million, net income $38.8 million, EPS $1.05.
- Period
- the fourth quarter ended December 31, 2022
- Revenue
- $628.2 million
- Net income
- $38.8 million
- EPS
- $1.05
- Result
- reported results
Exact text from the filing
Fourth quarter consolidated revenue was $628.2 million, a slight decrease from the prior year and prior quarter. Consolidated gross profit margin was 22.1%, down 90 basis points year-over-year and 50 basis points sequentially. Net income attributable to common stockholders was $38.8 million compared to $77.6 million in the prior year and $34.8 million in the prior quarter. Diluted earnings per share (EPS) was $1.05 compared to $2.07 in the prior year and $0.93 in the prior quarter.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.